Ablexis, Tri-Institutional Therapeutics Discovery Institute deal

Ablexis granted the institute non-exclusive rights to use the AlivaMab Mouse transgenic mouse technology to discover human antibodies. Ablexis will receive an eight-figure payment. Ablexis declined to...